GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 201 - 225 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgA Patient 3 11 mild
G69912LP
3319
IgM Patient 2 24 mild
G21675ZL
3212
IgG Patient 3 4 mild
G98068PA
3211
IgA Patient 2 3 mild
G35446HX
3193
IgM Patient 3 4 mild
G00068MO
3191
IgM Patient 3 11 mild
G64669AQ
3180
IgA Patient 3 -180 mild
G37383BH
3164
IgG Patient 3 11 mild
G96865DJ
3130
IgA Patient 3 11 mild
G24617OK
3123
IgA Patient 3 -180 mild
G19118WX
3115
IgM Patient 2 15 mild
G25559RS
3083
IgG Patient 2 3 mild
G42666HT
3078
IgA Patient 3 11 mild
G98068PA
3067
IgG Patient 2 24 mild
G47362BJ
3056
IgG Patient 3 11 mild
G64669AQ
3049
IgG Patient 2 15 mild
G15407YE
3047
IgA Patient 3 -180 mild
G99603GB
3036
IgA Patient 3 4 mild
G08340FW
3027
IgG Patient 2 15 mild
G64669AQ
3026
IgA Patient 3 11 mild
G37036SF
3025
IgM Patient 3 4 mild
G71142DF
3025
IgA Patient 3 11 mild
G37383BH
3023
IgM Patient 3 4 mild
G15407YE
3009
IgM Patient 2 3 mild
G15407YE
3006
IgG Patient 3 -180 mild
G98068PA
2991

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024